Clinical Trials Browser

Phase 1/2 × Recruiting × anlotinib × Clear all

NCT06970145 2025-11-18

Safety and Efficacy of Anlotinib in the Treatment of Recurrent Craniopharyngioma

Phase 1/2 Recruiting

Craniopharyngioma

NCT05301764 2024-10-15

A Study of LVGN6051 Combined with Anlotinib in Patient with Soft Tissue Sarcoma

Phase 1/2 Recruiting

Sarcoma